lung cancer
Dual-Target Nanoparticle Reduces Lung Cancer Drug Resistance
This drug carrier nanoparticle specifically targets EGFR-mutant lung cancer cells and releases two types of drugs—doubling the effectiveness.
Air Pollution Linked To Other Cancers, Not Just Lung
Long-term exposure to ambient fine particulate matter such as PM2.5 has been linked to increased risk of mortality for a range of cancers.
Sniffing Out Cancer Biomarkers
Researchers have used olfactory sensor neurons from mice to detect volatile organic compounds found specifically in urine samples from lung cancer patients.
Researchers Identify Early Lung Cancer Biomarker
HIP1 could serve as a biomarker of early lung cancer, helping patients get diagnosed and treated as soon as possible.
China Goes Tough On Tobacco Use With Anti-Smoking Laws
Although China has successfully pushed through landmark tobacco control laws, it remains to be seen how they will be enforced.
Snail Venom: A Sting In The Tail Of Cancer & Addiction
Cone snail toxins which selectively activate a specific nicotinic acetylcholine receptor could potentially treat lung cancer and nicotine addiction.
Artificial Antibodies To Treat Lung Cancer
Simpler to manufacture than typical antibodies, the repebody is a potentially cheaper lung cancer drug.
HSA Approves Lung Cancer Drug Giotrif®
Singaporean non-small cell lung cancer patients with EGFR mutations can look forward to new treatment possibilities with Boehringer Ingelheim's Giotrif®.
SIMM, Crown BioScience To Build Mouse Xenograft Model Center
Shanghai Institute of Materia Medica and Crown BioScience, Inc. have agreed to jointly build a mouse clinical trial center in China.
